Tresiba® for Children with Type 1 diabetes Approved in Canada

Tresiba®, an insulin degludec injection, has received an expanded approval for the treatment of Type 1 diabetes in pediatric patients in Canada. …

Lipid‐Lowering Medication Decreases Risk of Diabetic Retinopathy in Type 2 Diabetes

Using lipid-lowering medication with fibrates, including fenofibrate and statins reduces not only the incidence of diabetic retinopathy in patients …

American Diabetes Association Urges People to Sign Insulin Affordability Petition

The American Diabetes Association (ADA) is urging people to sign a petition to support those struggling with insulin affordability. More than …

FDA Issues Warning About Rare Infection with Commonly Used Diabetes Medication

The U.S. Food and Drug Administration is warning patients and doctors about a rare but serious infection that has been reported with a common class …

New Medications for Diabetes Management Have Additional Heart Benefits

A drug used to manage diabetes may reduce heart disease and death in people with diabetes regardless of their cholesterol levels and whether they are …

Down the Inhaled Insulin Path: The Road to Approval and Acceptance

Since the discovery of insulin over 85 years ago, scientists have been looking for ways to get it into the bodies of people without having to use …

Xeris Pharmaceuticals Submits New Drug Application for Glucagon Rescue Pen

Xeris Pharmaceuticals Inc., submitted an NDA to the U.S. Food and Drug Administration yesterday for its Glucagon Rescue Pen, the company’s lead …

Medicaid Expansion Leads to Greater Access to Diabetes Medications

Prescriptions for diabetes medications increased in the first two years after states expanded eligibility for Medicaid as part of the Affordable Care …

Blood Pressure Medication Found Effective as Type 1 Diabetes Therapy

Human clinical trials reveal a common blood pressure medication may be a safe and effective therapy for type 1 diabetes. It’s the first drug …

Insulin in a Pill: Daily Injections Maybe a Thing of the Past

Researchers at Harvard have developed an “insulin pill” that could change the way people manage their diabetes.  This could affect …